CardiovascularMedicine

Hemodynamic Monitoring in High-Risk Obstetrics Patients, I

with various phases of pregnancy is important in the interpretation of patients’ hemodynamic profiles and clinical findings. This section provides an overview of the expected hemodynamic changes that occur during pregnancy, at the time of delivery, and during the postpartum phase (Table 1).

Expected Hemodynamic Changes in Pregnancy Lt Col Elizabeth J. Bridges, USAF NC Capt Shannon Womble, USAF NC Capt Marlene Wallace, USAF NC Capt Jerry McCartney, USAF NC

C

ritically ill obstetrics patients may require care in an intensive care unit, or critical care nurses may assist in the management of these patients in the labor and delivery rooms. Critical care nurses are often called on because of their cardiopulmonary expertise, particularly in hemodynamic monitoring.1,2 Care of highrisk obstetrics patients is complex because clinical data must be interpreted within the context of the physiological changes that occur during pregnancy.3-5 This article provides an overview of the expected cardiovascular changes associated with pregnancy

and the pathological changes that occur with some of the more common conditions that require critical care, such as postpartum hemorrhage and cardiac disease. The discussion includes recommendations on how to interpret cardiovascular findings and hemodynamic data in light of the physiological changes associated with pregnancy. A subsequent article addresses hemodynamic monitoring during preeclampsia.

Expected Hemodynamic Changes in Pregnancy Recognition of the expected hemodynamic changes associated

Authors Elizabeth J. Bridges is the deputy commander of the 59th Clinical Research Squadron and the director of nursing research in the 59th Medical Wing, Lackland AFB, San Antonio, Tex. Shannon Womble, Marlene Wallace, and Jerry McCartney are staff nurses in the surgical intensive care unit of the 59th Medical Wing at Lackland AFB. To purchase reprints, contact The InnoVision Group, 101 Columbia, Aliso Viejo, CA 92656. Phone, (800) 8092273 or (949) 362-2050 (ext 532); fax, (949) 362-2049; e-mail, [email protected].

Blood Volume During pregnancy, total body water increases by approximately 6.5 to 8.5 L. Part of the increase reflects the water content of the fetus, placenta, and amniotic fluid (3500 mL) and an increase in maternal blood volume (1000-2000 mL); the remainder is due primarily to an expansion in plasma volume (1200-1300 mL) and an increase in red blood cell mass (300400 mL).17 Plasma volume increases by as much as 11% at the seventh week of pregnancy and peaks at approximately 32 weeks, with a 40% to 50% increase in plasma volume compared with nonpregnant levels (Figure 1).18 Red blood cell mass increases by approximately 20% throughout pregnancy, depending on whether the mother is receiving iron supplementation.13,19-21 The increase in blood volume is protective, as an uncomplicated vaginal delivery causes 500 to 600 mL of blood loss and the mean blood loss with a cesarean delivery is 1000 mL.22,23 The disparity between increased plasma volume and the smaller increase in red cell mass results in a physiological or dilutional anemia. For example, the hematocrit decreases from a normal nonpregnant value of 0.41 to a minimum of

CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003 53

CardiovascularMedicine Table 1 Hemodynamic changes during pregnancy6-16 Time

Parameter

Labor† (during Before Third trimester,* % change (labo- contractions), ratory value) pregnancy % change

After delivery

Blood volume, L

4.2

↑ 48% (6.2 L)

No change

↓ 0.5-1.0 L (10%-20%)

Plasma volume, L

2.4

↑ 40-50% (3.4-4.6 L)

No change

↓ 10% by day 5 Total decrease in blood volume (cells + plasma) = 20%

Hemoglobin, g/L

120-160

↓ 9% (110-120 g/L)

No change

0.41

↓ 10-25% (0.31-0.37)

No change

Stable, then ↓ 6% by day 5

Blood pressure, mm Hg Systolic Diastolic

108 67

↑ 5-10% (decreased through week 24) ↑ 0-10% (decreased through week 24)

Increases Increases

Returns to prelabor values at 24 hours Returns to prelabor values at 24 hours

Cardiac output, L/min

4.9

↑ 27-50% (7.3 L/min)

↑ 11

Returns to prelabor values at 1 hour and to prepregnancy values at 10-14 days

Stroke volume, mL per beat

65

↑ 21-30% (79-85 mL per beat)

↑ 11

Returns to prelabor values at 24 hours and to prepregnancy values at 12 weeks to 1 year

Heart rate, beats per minute

75

↑ 16-29% (87-95 beats per minute)

↑ 0-20

Returns to prelabor values at 1 hour and to prepregnancy values at 6 to 12 weeks

↓ 0-20% (↓ 34% to nadir at 14-24 weeks)

No change

2-6

No change

ND

ND

15-25 8-12 6-12

No change No change No change

ND ND ND

Unchanged throughout pregnancy Unchanged throughout pregnancy Unchanged throughout pregnancy

Pulmonary vascular resistance, dyn · s · cm-5

220

↓ 25% (175 dyn · s · cm-5)

ND

ND

Colloid oncotic pressure, mm Hg

20

ND

ND

ND

Hematocrit, proportion of 1.0

Systemic vascular 800-1200 resistance, dyn · s · cm-5 Central venous pressure, mm Hg Pulmonary artery pressures, mm Hg Systolic End-diastolic Wedge

Returns to prepregnancy values at 12 weeks to 1 year

*Compared with value before pregnancy. †Compared with third trimester/prelabor values. ↑ indicates increase; ↓, decrease; ND, no data.

0.31 to 0.37 in late pregnancy, and the hemoglobin level decreases by approximately 9%. The actual decrease depends on iron supplementation.11 Blood Pressure Arterial blood pressure decreases early in pregnancy; mean arterial

54 CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003

pressure has decreased by approximately 10% at the eighth week. This decrease is primarily due to a decrease in diastolic pressure. The blood pressure continues to decrease, reaching its nadir or lowest point (6 mm Hg [SD 1 mm Hg] less than prepregnant value) at approximately 16 to 24

weeks.16,24,25 After the 16th week, the blood pressure progressively increases back to baseline (nonpregnant blood pressure) at term.16 Two factors should be considered when blood pressure is evaluated during pregnancy. First, blood pressure is affected by the pregnant

% change from value before pregnancy

pressure obtained by various techniques (arterial catheter versus automated cuff or auscultation) is not recommended. For example, in postpartum women, measurements of systolic blood pressure obtained by using an automated cuff were significantly lower than measurements obtained by using an arterial catheter, whereas the measurements of diastolic pressures were similar.27 In patients with preeclampsia, measurements of systolic pressure obtained by using an arterial catheter were 19 mm Hg higher than measurements obtained by using an automated cuff.28,29 Conversely, measurements of systolic pressure obtained by using an automated cuff tended to be higher than measurements obtained by using auscultation, and measurements of diastolic pressure tended to be lower (4-8 mm Hg).28,30 However, in normotensive patients, average measurements of systolic pressure obtained by using an arterial catheter were 5 mm Hg lower than those obtained by using an automated cuff.

Plasma volume

+50 +40 +30

Erythrocyte volume (iron supplements)

+20

Erythrocyte volume (no iron supplements)

+10 0 Hematocrit (iron supplements) Hematocrit (no iron supplements)

-10 -20 4

8

12

16

20

24

28

32

36

40

Duration of pregnancy (weeks)

Figure 1 Changes in plasma volume, erythrocyte volume, and hematocrit during pregnancy. The increase in plasma volume is more rapid than the increase in erythrocyte volume, causing the “physiological anemia of pregnancy,” which can be partially corrected with iron supplements. Reprinted from Pitkin et al,18 with permission.

woman’s body position. Early in pregnancy, blood pressure is highest in the upright or sitting position, intermediate in the supine position, and lowest in the side-lying position.26 In the third trimester, the

effect of body position on blood pressure is variable, depending on the relative degree of compression of the inferior vena cava and the aorta by the gravid uterus (Table 2). Second, comparison of blood

Table 2 Hemodynamic alterations in response to position change late in the third trimester of pregnancy* Indice

Left lateral

Right lateral

Supine

Sitting

Standing

Knee-chest

MAP (mm Hg)

90 ± 6

90 ± 5

90 ± 8

90 ± 8

91 ± 14

95 ± 6

CO (L/min)

6.6 ± 1.4

6.8 ± 1.3

6.0 ± 1.4†

6.2 ± 2.0

5.4 ± 2.0

6.9 ± 2.1

HR (beats/min)

82 ± 10

87 ± 12

84 ± 10

91 ± 11

107 ± 17*

93 ± 12

1321 ± 305

1437 ± 338

1217 ± 254

1319 ± 394

1233 ± 289

76 ± 16

81 ± 33

101 ± 45

102 ± 35

117 ± 35*

79 ± 27

8±2

7±1

6±3

4±4

4±2

8±3

3

3±2

3±2

1±1

1±2

3±2

SVR (dyne · sec · cm-5) 1210 ± 266 PVR (dyne · sec · cm-5) PAWP (mm Hg) CVP (mmHg)

*Values are means ± SDs. CO indicates cardiac output; CVP, central venous pressure; HR, heart rate; MAP, mean arterial pressure; PAWP, pulmonary artery wedge pressure; PVR, pulmonary vascular resistance; SVR, systemic vascular resistance. †P < .05 compared with left lateral position. Reprinted from Clark et al,26 with permission.

CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003 55

CardiovascularMedicine Cardiac Output Cardiac output increases early in pregnancy (13%-20% by 5-11 weeks). The early changes are attributed to an increase in stroke volume and are independent of metabolic rate and pregnancy-induced increases in blood volume25,31 (Figure 2). The early increase in cardiac output may be triggered by a decrease in systemic vascular resistance (SVR).8,24 Cardiac output continues to increase throughout pregnancy; peak values (27%-50% higher than baseline) occur late in the second trimester (eg, an increase from a prenatal value of 4.9 L/min to 7.3 L/min).25,33 The later increase is attributed primarily to an increase in heart rate.10,25 During the third trimester, the change in cardiac output is highly

variable. Grouped data indicate a decrease; however, data on individual women indicate an increase, a decrease, or no change.9,10,15,34,35 The variability may reflect changes related to body position (eg, a decrease in stroke volume due to compression of the inferior vena cava when the pregnant woman is supine) or to the technique used to measure the output.26 Two important points about measurement of cardiac output are as follows: First, throughout pregnancy, cardiac output should be measured with the pregnant woman in the same position (eg, left lateral decubitus) because output is lower in supine and standing positions (Table 2).26 Second, recommendations for the use of cardiac index are equivocal because the correlation between car-

50 46

48

47

50

50

48

44

% change

40

38 30

30 25 20

10

32

32 29

27

27

17

16

26

17

17 11

10

29

11

11

12

13

7 5

5

0 5

8

12

16

20

24

28

32

36

38

Weeks Heart rate

Stroke volume

Cardiac output

Figure 2 Percentage change in heart rate, stroke volume, and cardiac output, measured with the pregnant woman in the lateral position, throughout pregnancy compared with prepregnancy values. Based on work from Robson et al25 and reprinted from Elkayam et al,32 with permission from the American Physiological Society.

56 CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003

diac output and body surface area during pregnancy is poor.35 Stroke Volume Stroke volume begins to increase (approximately 6-10 mL per beat) early in pregnancy (weeks 5 to 8)25,36 and continues to increase throughout pregnancy. Maximal stroke volume (32% greater than nonpregnant levels) occurs at 16 to 24 weeks.25 After the peak at 24 weeks, the stroke volume remains the same or decreases slightly throughout the remainder of the pregnancy.10,25 Heart Rate Heart rate increases by approximately 8/min early in pregnancy.24 This early increase is a compensatory response to the decrease in SVR.24 The heart rate continues to increase to a peak (15-20/min greater than prepregnant value) at term.10,25,36 Systemic Vascular Resistance SVR begins decreasing early in pregnancy (30% less than prepregnant value at 8 weeks)24,25,37 and continues to decrease, reaching its lowest point (nadir 34% less than prepregnant value) between approximately the 14th to 24th weeks.16,34 After reaching the nadir, the SVR progressively increases toward nonpregnant values at term.7,34 The decrease in SVR is thought to be due to vasodilatation mediated by gestational hormones, prostaglandins, and creation of low-resistance vascular beds in the uterus and placenta.38 Pulmonary Artery Pressures Despite an approximate increase of 32% to 47% in pulmonary blood flow during pregnancy, pulmonary

artery pressures do not change significantly during pregnancy because of an offsetting decrease in pulmonary vascular resistance.7,39,40 In addition, although the intravascular volume increases by approximately 40% to 50% and left ventricular enddiastolic volume by 10 to 24 mL at 24 weeks,33 the pulmonary artery wedge pressure (PAWP) does not increase. Although pulmonary artery pressures remain within normal limits during pregnancy, the risk for pulmonary edema is increased when PAWPs are lower because of a pregnancy-induced decrease in colloid osmotic pressure.41 The risk of pulmonary edema is particularly high in patients with pregnancy-induced hypertension and preeclampsia, because these patients have a further decrease in colloid osmotic pressure.7,42-46 Left Ventricular Wall Thickness Left ventricular mass increases during pregnancy because of an increase in the thickness of the left ventricular wall, although this change is not generally detected on electrocardiograms. The increase in wall thickness is greater than the increase in end-diastolic radius, resulting in concentric hypertrophy.10,25,33,47 Oxygen Delivery Early in pregnancy, oxygen delivery exceeds oxygen consumption, primarily because of the increase in cardiac output, resulting in a decrease in the arteriovenous oxygen difference.48 However, oxygen consumption progressively increases throughout pregnancy, peaking at term (20%-30% greater than prepregnant levels).49 During the third trimester, the progressive increase in

oxygen consumption relative to oxygen delivery results in a return of the arteriovenous oxygen difference back to prepregnant levels. One factor to be considered when interpreting changes in oxygen delivery is that in the third trimester, arterial oxygen content (1.34 × hemoglobin level × arterial oxygen saturation) and mixedvenous oxygen content (1.34 × hemoglobin level× venous oxygen saturation) are decreased. The decrease is due to the physiological anemia of pregnancy.49 The implication of this decrease in oxygen content is that although cardiac output may increase, no significant increase in oxygen delivery occurs because of the offsetting effect of the decreased oxygen content (oxygen delivery = cardiac output × oxygen content).

P < .001) and were associated with an 11% increase in cardiac output (6.31 ± 1.79 L/min to 7.12 ± 1.93 L/min, P < .001).56 The contractioninduced increase in cardiac output is also related to the phase of labor; values at the time of full cervical dilatation are 1 to 2 L/min greater than prelabor values.53,57 Oxygen consumption also increases approximately 23% during labor.58 The hemodynamic effects of epidural and spinal anesthesia depend on the level of the block. For example, “low-block” epidural anesthesia extending to the 10th thoracic dermatome does not markedly affect the hemodynamic response to labor. However, regional anesthesia can cause a decrease in preload because of venodilatation with resultant hypotension.54,59

Hemodynamic Changes During Labor

Hemodynamic Changes After Delivery

During labor, hemodynamic changes depend on the pregnant woman’s body position (greater increase in cardiac output in the supine position than in the left lateral decubitus position),50-52 phase of labor,53 and the type of anaesthetics/ analgesics used.54 Pain and anxiety associated with labor may contribute to as much as 50% to 60% of the increase in labor-related changes in cardiac output.32,55 In addition, uterine contractions, which translocate approximately 300 to 500 mL of blood into the central circulation, further increase the cardiac output by augmenting the stroke volume.56 For example, in term normotensive pregnant women, uterine contractions increased left ventricular stroke volume by 16% (75 ± 15 mL per beat to 89 ± 17 mL per beat,

After an uncomplicated delivery, the heart rate, stroke volume, mean arterial pressure, and cardiac output remain increased during the immediate postpartum period. Heart rate and cardiac output return to prelabor values at 1 hour postpartum, and the mean arterial pressure and stroke volume return to prelabor values by 24 hours.8,53 Beginning approximately 24 hours after birth, the cardiac output progressively decreases to nonpregnant values during the next 10 to 14 days.6,10,12,53,57,60 The heart rate returns to prepregnant levels at 6 to 12 weeks.15,36 However, at 6 to 12 weeks postpartum, stroke volume and left ventricular enddiastolic volume remain higher than preconception values, and SVR remains lower than preconception values.6 Even at 1 year, hemodynamic

CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003 57

CardiovascularMedicine values may remain altered from preconception values, with greater changes in multiparous women.36 During the postpartum phase, an acute decrease in blood volume occurs within the first hour after delivery (10% for vaginal delivery and 17% for cesarean delivery). Blood volume continues to decrease until day 5 for both types of delivery. The acute decrease reflects the delivery-related blood loss; the later changes reflect diuresis and a decrease in plasma volume.22 Despite the decrease in blood volume, for vaginal deliveries, the hematocrit remains relatively stable and may even increase, reflecting the predominant loss of plasma. In women who have cesarean delivery, the hematocrit is relatively stable during the first 24 hours after delivery and then progressively decreases (about 6%) by day 5.23 Knowledge of the expected postpartum changes in hemodynamic variables, blood volume, and hematocrit is important to detect signs of postpartum hemorrhage. Because of the increased blood volume during pregnancy, a delivery-related loss of up to 1000 mL may be well tolerated and not cause a compensatory cardiovascular response (eg, increased heart rate compared with predelivery values). However, an acute decrease in hematocrit or indications of cardiovascular compensation, such as increased heart rate and decreased stroke volume compared with predelivery values, are not expected findings and may indicate severe hemorrhage (Figure 3).12 An important assessment point is that in most instances of postpartum hemorrhage, blood pressure and cardiac output remain increased because of the compensatory

58 CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003

increase in heart rate.11 Therefore, a decrease in blood pressure and cardiac output are not expected changes in the immediate postpartum period and warrant rapid assessment to detect the cause. Use of a pulmonary artery catheter is not generally required in cases of postpartum hemorrhage unless the patient has additional

complications or comorbid conditions, such as acute lung injury or underlying cardiopulmonary disease.61

Indications for Hemodynamic Monitoring in Pregnancy The indications for invasive hemodynamic monitoring in pregnant women are similar to those for

100 90 Heart 80 rate (beats/min) 70 60 50 100 Stroke volume (ml)

90 80 70 60 7

Cardiac output (l/min)

6

5 100 Mean arterial pressure (mm Hg)

90 80 70 60 38 weeks pregnancy

1

2

6

10

14

(Days) Postnatal Transfusion

Figure 3 Hemodynamic changes in a woman with an atonic uterus who experienced a massive primary postpartum hemorrhage (estimated blood loss 1900 mL). Exploration of the uterus revealed no abnormalities, and the bleeding was eventually controlled with intravenous oxytocin. The woman was transfused with 4 U of blood during the first 36 hours after delivery. The first postpartum measurement was performed 12 hours after delivery. Reproduced from Robson et al,12 with permission from the American College of Obstetricians and Gynecologists.

nonpregnant persons, with a limited number of additional pregnancyspecific indications62 (Table 3). The following section focuses on 1 of the 2 most common indications for invasive hemodynamic monitoring in pregnancy: cardiovascular disease. A separate article focuses on the other common indication for hemodynamic monitoring: preeclampsia. Cardiovascular Disease Although a relatively small number of pregnancies (1%-2%) involve women with cardiac disease, cardiovascular disease is the leading cause of indirect maternal death during pregnancy.63 The risk of morbidity and mortality with cardiovascular disease depends on the type of disease, the presence of pulmonary hypertension or cyanosis, ventricular function, functional capacity, and history of cardiac surgery.63,66 Maternal mortality increases as the

New York Heart Association functional class increases (Table 4). Use of a pulmonary catheter is recommended only when measurements of pressure and cardiac output of the left side of the heart are required to guide therapy, for example, in patients with complicated mitral or aortic stenosis or pulmonary hypertension or patients with impaired functional status (eg, New York Heart Association functional class III or IV).62,66-70 However, use of a pulmonary artery catheter is not generally recommended for

patients with right ventricular outflow obstruction, low pulmonary artery pressure, or right-to-left shunt. Additionally, the risk-to-benefit ratio of pulmonary artery catheterization should be weighed in conditions associated with an increased prevalence of catheter-related complications (eg, Eisenmenger syndrome).71,72 Challenges in the Diagnosis of Heart Disease Physical assessment of pregnant patients who have cardiac disease is challenging because of the normal

Table 3 Indications for hemodynamic monitoring in pregnancy61-65 Severe pregnancy-induced hypertension with pulmonary edema or persistent oliguria Preexisting cardiovascular disease (mitral or aortic stenosis, pulmonary hypertension, imparied functional status) Sepis with refractory hypotension or oliguria Refractory pulmonary edema, heart failure, or oliguria Intraoperative or intrapartum cardiovascular decompensation Massive blood and volume loss or replacement Acute respiratory distress syndrome

Table 4 Risk associated with cardiovascular disease in pregnancy* Minimal risk (0%-1% mortality)

Moderate risk (5%-15% mortality)

High risk (25%-50% mortality)

Arterial septal defect

Mitral stenosis, NYHA class III/IV

Pulmonary hypertension

Ventricular septal defect

Aortic stenosis

Aortic coarctation with valvular involvement

Patent ductus arteriosus

Aortic coarctation without valvular involvement

Marfan syndrome with aortic involvement

Pulmonic valve disease

Tetralogy of Fallot, uncorrected

Tricuspid valve disease

Previous myocardial infraction

Tetralogy of Fallot, corrected

Marfan syndrome, normal aorta

Bioprosthetic valve

Mitral stenosis with atrial fibrillation

Mitral stenosis, NYHA class I/II

Artificial valve

*NYHA indicates New York Heart Association functional classification: I, Patients with cardiac disease but without resulting limitation of physical activity; II, Patients with cardiac disease resulting in slight limitation of physical activity; III, Patients with cardiac disease resulting in marked limitation of physical activity; IV, Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.67 Reprinted from “Cardiac Disease in Pregnancy,”63 copyright 1993, with permission from Elsevier Science.

CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003 59

CardiovascularMedicine changes that occur during pregnancy. For example, dyspnea, edema, increased heart rate, midsystolic murmur due to pulmonic or tricuspid regurgitation, and shifted apical pulse are all expected findings in pregnancy. Compared with findings on prepregnancy chest radiographs, during pregnancy, the cardiac silhouette appears enlarged with increased lung markings. Although these changes typically indicate increased pulmonary venous pressure due to left ventricular failure or mitral valve disease, they are expected during pregnancy. The apparent enlargement of the heart is due in part to the increased thickness of the left ventricular wall and to the upward displacement of the heart by the gravid uterus. Additionally, an increase in heart size occurs because of increased preload.9,24,49 These changes in radiographic findings complicate the diagnosis in pregnant patients with suspected cardiovascular disease. Of note, all other pulmonary and cardiac radiographic characteristics indicative of cardiovascular disease remain unchanged during pregnancy. The pregnancy-induced distention of the heart leads to dilatation of the valvular rings and subsequent regurgitant murmurs.50,51 Common findings on auscultation include a loud, split S1 (due to delayed mitral valve closure) and early to midsystolic ejection murmurs (eg, tricuspid and mitral valve regurgitation). These findings are not generally considered pathological.52 However, the presence of diastolic, pansystolic, or late systolic murmurs and an S3 heart sound may be associated with a cardiac abnormality and require further exploration.49,53

60 CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003

Interaction Between PregnancyInduced Cardiovascular Changes and Cardiac Disease Regardless of the disease process, management of pregnant patients who have cardiac disease requires an understanding of the expected physiological changes (increased intravascular volume, cardiac output, and heart rate and decreased vascular resistance), because these changes may exacerbate or minimize cardiovascular compromise.73 For example, increased intravascular volume may be poorly tolerated in women who have mitral regurgitation.74 In contrast, in patients with aortic stenosis with ventricular hypertrophy, increased preload may be beneficial in maintaining stroke volume and cardiac output. In women with aortic stenosis with ventricular hypertrophy, a PAWP that is “normal” may be insufficient to maintain cardiac output and a higher value (eg, 18 mm Hg) may be needed.75 The pregnancy-induced increase in heart rate may cause cardiovascular compromise for patients with valvular dysfunction (eg, mitral stenosis) in whom diastolic filling time is heart-rate dependent. Patients who have mitral stenosis, the most common rheumatic valvular abnormality in pregnant women, may benefit from beta-blockade to control the heart rate and diuresis to minimize pulmonary congestion.76 However, the decision to use diuretics must be made with care because PAWP is not an accurate indicator of left ventricular preload in patients with mitral stenosis, and excessive decrease of intravascular volume may compromise uteroplacental circulation. The pregnancy-related decrease in vascular resistance may be benefi-

cial for patients with regurgitant disease (eg, mitral or aortic regurgitation), particularly because of the increase in intravascular volume.74 However, cardiovascular compromise may occur in the postpartum period as vascular resistance returns to normal. If cardiovascular compromise occurs, treatment may include vasodilator therapy (hydralazine) if vascular resistance is increased and diuretics for pulmonary edema.73 In contrast, the expected decrease in vascular resistance may worsen the hemodynamic effects of a stenotic lesion (eg, aortic stenosis) or rightto-left shunts.66,77 The potential for cardiovascular compromise is high during labor, delivery, and the immediate postpartum period. In patients at risk for formation or dissection of aortic aneurysm (eg, women with Marfan syndrome), the careful use of analgesics and β-blocker therapy is recommended to minimize the labor-related fluctuations in cardiac output and blood pressure.59,73,78 During the postpartum period, the increase in intravascular volume may cause pulmonary edema in patients who have mitral stenosis.70 In contrast, any factor that decreases intravascular volume or causes hypotension (eg, postpartum hemorrhage) may worsen preload conditions, such as aortic stenosis. Acknowledgments The opinions and assertions contained herein are the private views of the authors and are not to be construed as the official policy or position of the US government, the Department of Defense, or the Department of the Air Force.

References 1. Lapinsky SE, Kruczynski K, Seaward GR, Farine D, Grossman RF. Critical care management of the obstetric patient. Can J Anaesth. 1997;44:325-329. 2. Mabie WC, Sibai BM. Treatment in an obstetric intensive care unit. Am J Obstet Gynecol. 1990;162:1-4.

3. Fuschino W. Physiologic changes of pregnancy: impact on critical care. Crit Care Nurs Clin North Am. 1992;4:691-701. 4. Martin JM. Invasive hemodynamic monitoring in pregnancy. Crit Care Nurs Clin North Am. 1992;4:653-657. 5. McCormack DM. Care of the obstetric patient in the traditional intensive care unit. Crit Care Nurs Q. November 1998;21:1-11. 6. Capeless EL, Clapp JF. When do cardiovascular parameters return to their preconception values? Am J Obstet Gynecol. 1991; 165:883-886. 7. Clark SL, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol. 1989;161: 1439-1442. 8. Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv. 1994;49(12 suppl):S1-S14. 9. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol. 1990;76: 1061-1069. 10. Mabie WC, DiSessa TG, Crocker LG, Sibai BM, Arheart KL. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol. 1994;170:849-856. 11. Milman N, Byg KE, Agger AO. Hemoglobin and erythrocyte indices during normal pregnancy and postpartum in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand. 2000;79:89-98. 12. Robson SC, Boys RJ, Hunter S, Dunlop W. Maternal hemodynamics after normal delivery and delivery complicated by postpartum hemorrhage. Obstet Gynecol. 1989; 74:234-239. 13. Thomsen JK, Prien-Larsen JC, Devantier A, Fogh-Andersen N. Low dose iron supplementation does not cover the need for iron during pregnancy. Acta Obstet Gynecol Scand. 1993;72:93-98. 14. Thomsen JK, Fogh-Andersen N, Jaszczak P, Giese J. Atrial natriuretic peptide (ANP) decrease during normal pregnancy as related to hemodynamic changes and volume regulation. Acta Obstet Gynecol Scand. 1993;72:103-110. 15. van Oppen AC, van der Tweel I, Alsbach GP, Heethaar RM, Bruinse HW. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet Gynecol. 1996; 88:40-46. 16. Clapp JF III, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol. 1997;80:1469-1473. 17. Theunissen IM, Parer JT. Fluid and electrolytes in pregnancy. Clin Obstet Gynecol. 1994;37:3-15. 18. Pitkin RM. Nutritional support in obstetrics and gynecology. Clin Obstet Gynecol. 1976;19:489-513. 19. Milman N, Bergholt T, Byg KE, Eriksen L, Graudal N. Iron status and iron balance during pregnancy: a critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand. 1999;78:749-757. 20. Chesley LC. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol. 1972;112:440-450. 21. Thomsen JK, Fogh-Andersen N, Jaszczak P. Atrial natriuretic peptide, blood volume, aldosterone, and sodium excretion during

22.

23. 24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

34.

35.

36. 37.

twin pregnancy. Acta Obstet Gynecol Scand. 1994;73:14-20. Pritchard J, Baldwin R, Dickey J, Wiggins K. Blood volume changes in pregnancy and the puerperium, II: red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. Am J Obstet Gynecol. 1962;84: 1271-1282. Ueland K. Maternal cardiovascular dynamics, VII: intrapartum blood volume changes. Am J Obstet Gynecol. 1976;126:671-677. Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP, Peeters LH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993;169: 1382-1392. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060-H1065. Clark SL, Cotton DB, Pivarnik JM, et al. Position change and central hemodynamic profile during normal third-trimester pregnancy and post partum. Am J Obstet Gynecol. 1991;164:883-887. Kirshon B, Lee W, Cotton DB, Giebel R. Indirect blood pressure monitoring in the postpartum patient. Obstet Gynecol. 1987;70:799-801. Brown MA, Robinson A, Buddle M. Accuracy of automated blood pressure recorders in pregnancy. Aust N Z J Obstet Gynecol. 1998;38:262-265. Natarajan P, Shennan AH, Penny J, Halligan AW, de Swiet M, Anthony J. Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia. Am J Obstet Gynecol. 1999;181:1203-1210. Gupta M, Shennan AH, Halligan A, Taylor DJ, de Swiet M. Accuracy of oscillometric blood pressure monitoring in pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1997;104:350-355. Spaanderman ME, Meertens M, van Bussel M, Ekhart TH, Peeters LL. Cardiac output increases independently of basal metabolic rate in early human pregnancy. Am J Physiol Heart Circ Physiol. 2000;278:H1585-H1588. Elkayam U, Gleicher N. Hemodynamic and cardiac function during normal pregnancy and the puerperium. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy. New York, NY: Wiley-Liss; 1998:3-19. Gilson GJ, Samaan S, Crawford MH, Qualls CR, Curet LB. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol. 1997; 89:957-962. Bosio PM, McKenna PJ, Conroy R, O’Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:978-984. van Oppen AC, van der Tweel I, Duvekot JJ, Bruinse HW. Use of cardiac index in pregnancy: is it justified? Am J Obstet Gynecol. 1995;173:923-928. Clapp JF III. Maternal heart rate in pregnancy. Am J Obstet Gynecol. 1985;152:659-660. Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol. 1989;161:1449-1453.

38. Bhagwat AR, Engel PJ. Heart disease and pregnancy. Cardiol Clin. 1995;13:163-178. 39. Kitabatake A, Inoue M, Asao M, et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation. 1983;68:302-309. 40. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial changes in pulmonary haemodynamics during human pregnancy: a non-invasive study using Doppler echocardiography. Clin Sci (Lond). 1991;80:113-117. 41. Bungum L, Tollan A, Oian P. Antepartum to postpartum changes in transcapillary fluid balance. Br J Obstet Gynaecol. 1990; 97:838-842. 42. Benedetti TJ, Kates R, Williams V. Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol. 1985;152:330-334. 43. Oian P, Maltau JM. Calculated capillary hydrostatic pressure in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1987;157:102-106. 44. Oian P, Maltau JM. Transcapillary forces in normal pregnant women. Acta Med Scand Suppl. 1985;693:19-22. 45. Sibai BM, Mabie WC. Hemodynamics of preeclampsia. Clin Perinatol. 1991;18:727-747. 46. Wu PY, Udani V, Chan L, Miller FC, Henneman CE. Colloid osmotic pressure: variations in normal pregnancy. J Perinat Med. 1983;11:193-199. 47. Poppas A, Shroff SG, Korcarz CE, et al. Serial assessment of the cardiovascular system in normal pregnancy: role of arterial compliance and pulsatile arterial load. Circulation. 1997;95:2407-2415. 48. Clapp JF III, Seaward BL, Sleamaker RH, Hiser J. Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol. 1988;159:1456-1460. 49. Hankins GD, Clark SL, Uckan E, Van Hook JW. Maternal oxygen transport variables during the third trimester of normal pregnancy. Am J Obstet Gynecol. 1999;180:406-409. 50. Danilenko-Dixon DR, Tefft L, Cohen RA, Haydon B, Carpenter MW. Positional effects on maternal cardiac output during labor with epidural analgesia. Am J Obstet Gynecol. 1996;175:867-872. 51. Kjeldsen J. Hemodynamic investigations during labour and delivery. Acta Obstet Gynecol Scand Suppl. 1979;89:1-252. 52. Ueland K, Hansen JM. Maternal cardiovascular dynamics, II: posture and uterine contractions. Am J Obstet Gynecol. 1969;103:1-7. 53. Robson SC, Dunlop W, Boys RJ, Hunter S. Cardiac output during labour. Br Med J (Clin Res Ed). 1987;295:1169-1172. 54. Ramanathan J, D’Alessio J, Geller E, Rudick V, Niv D. Analgesia and anesthesia during pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy. New York, NY: Wiley-Liss; 1998:285-313. 55. Henricks C, Quilligna E. Cardiac output during labor. Am J Obstet Gynecol. 1956;71:953-972. 56. Lee W, Rokey R, Miller J, Cotton DB. Maternal hemodynamic effects of uterine contractions by M-mode and pulsedDoppler echocardiography. Am J Obstet Gynecol. 1989;161:974-977. 57. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68:540-543. 58. Eliasson AH, Phillips YY, Stajduhar KC, Carome MA, Cowsar JD Jr. Oxygen con-

CRITICALCARENURSE Vol 23, No. 4, AUGUST 2003 61

CardiovascularMedicine

59. 60.

61.

62.

63. 64.

65.

66.

sumption and ventilation during normal labor. Chest. 1992;102:467-471. Naulty J. Epidural analgesia for labor. In: Norris M, ed. Obstetric Anaesthesia. Philadelphia, Pa: JB Lippincott; 1993:319-340. Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94:1028-39. American College of Obstetricians and Gynecologists. ACOG educational bulletin. Postpartum hemorrhage. Number 243, January 1998 (replaces No 143, July 1990). Int J Gynaecol Obstet. 1998;61:79-86. Invasive hemodynamic monitoring in obstetrics and gynecology. ACOG Technical Bulletin Number 175—December 1992. Int J Gynaecol Obstet. 1993;42:199-205. Cardiac disease in pregnancy. ACOG technical bulletin number 168—June 1992. Int J Gynaecol Obstet. 1993;41:298-306. Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association. J Am Coll Cardiol. 1998; 32:1486-1588. Clark SL, Cotton DB. Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia. Am J Obstet Gynecol. 1988;158:453-458. Warnes C, Elkayam U. Congenital heart disease and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac Problems in

67.

68.

69.

70.

71.

72.

73.

Pregnancy. New York, NY: Wiley-Liss; 1998:39-53. The Criteria Committee of the New York Heart Association. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. In: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Boston, Mass: Little Brown & Co; 1994:253-256. Ben-Ami M, Battino S, Rosenfeld T, Marin G, Shalev E. Aortic valve replacement during pregnancy: a case report and review of the literature. Acta Obstet Gynecol Scand. 1990;69:651-653. Clark SL, Horenstein JM, Phelan JP, Montag TW, Paul RH. Experience with the pulmonary artery catheter in obstetrics and gynecology. Am J Obstet Gynecol. 1985;152: 374-378. Clark SL, Phelan JP, Greenspoon J, Aldahl D, Horenstein J. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol. 1985;152:984-988. Devitt JH, Noble WH, Byrick RJ. A SwanGanz catheter related complication in a patient with Eisenmenger’s syndrome. Anesthesiology. 1982;57:335-337. Weiss BM, Atanassoff PG. Cyanotic congenital heart disease and pregnancy: natural selection, pulmonary hypertension, and anesthesia. J Clin Anesth. 1993;5:332-341. Hjertberg R, Belfrage P, Hagnevik K. Hemodynamic measurements with SwanGanz catheter in women with severe proteinuric gestational hypertension

74. 75.

76.

77. 78.

(pre-eclampsia). Acta Obstet Gynecol Scand. 1991;70:193-198. Elkayam U. Pregnancy and cardiovascular disease. In: Heart Disease. Philadelphia, Pa: WB Saunders Co; 1997:1843-1863. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1999;181:924-928. Esop M, Sareli P. Rheumatic valvular disease and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy. New York, NY: Wiley-Liss; 1998:55-60. Clark S, Cotton D, Hankins GD, Phelan J. Critical Care Obstetrics. Malden, Mass: Blackwell Science; 1997. Elkayam U, Ostrzega E, Shotan A, Mehra A. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med. 1995;123:117-122.